Coherus Oncology
CHRS
CHRS
156 hedge funds and large institutions have $278M invested in Coherus Oncology in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 49 increasing their positions, 53 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
20% less capital invested
Capital invested by funds: $348M → $278M (-$69.4M)
24% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 42
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
156
Holding in Top 10
1
Calls
$3.15M
Puts
$1.19M
Top Buyers
| 1 | +$8.74M | |
| 2 | +$4.83M | |
| 3 | +$4.75M | |
| 4 |
Barclays
London,
United Kingdom
|
+$3.69M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.63M |
Top Sellers
| 1 | -$22.4M | |
| 2 | -$16.5M | |
| 3 | -$8.76M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$7.31M |
| 5 |
Rafferty Asset Management
New York
|
-$3.28M |